How tifacogin could not captivate severe community-acquired pneumonia

Am J Respir Crit Care Med. 2011 Jun 1;183(11):1449-50. doi: 10.1164/rccm.201103-0407ED.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Community-Acquired Infections
  • Humans
  • Pneumonia / drug therapy*
  • Proteins / therapeutic use*
  • Severity of Illness Index
  • Survival Analysis
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Proteins
  • Tifacogin